AURKA's novel substrate, LKB1, when phosphorylated at Ser299, leads to LKB1 and AMPK dissociation, impairing the AMPK signaling pathway and promoting NSCLC growth and migration (Zheng et al. 2018). Here, AURKA is linked to non-small cell lung carcinoma.